Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 

Click here to view
our current issue



 
 

New Horizons in Biopharma Treatments




In recent years, biological drugs have been developed for many diseases. These drugs have shown significant success in more complex diseases, where chemical (small molecule) drugs have not been that effective. According to The Business Research Company Market report, the biological drugs market was estimated at $258 billion in 2018, and continues growing at a compound annual growth rate of 12.4%.

These developments have been enabled by the invention of the chromatography separation techniques that allow researchers to purify antibodies and proteins to very high purity using various methods of separation such as affinity chromatography, ion exchange, hydrophobic interaction, size exclusion, and others.

Roumen Bogoev at GenScript (October 2019)

Keywords: GenScript, Biopharma, Biologics, Small molecule, complex diseases, purification, chromatography

    View full article    |    Back to Biopharma section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | caitlin@samedanltd.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |